Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Regal Rexnord
RRX
$11.8B
| $219M | 0.14% |
1,556,578
-51,678
| -3% | -$7.48M |
|
152
United Therapeutics
UTHR
$23B
| $219M | 0.14% |
975,830
+208,404
| +27% | +$51.4M |
|
153
Johnson & Johnson
JNJ
$626B
| $218M | 0.14% |
1,404,862
-97,626
| -6% | -$15.8M |
|
154
Deckers Outdoor
DECK
$13.1B
| $217M | 0.14% |
2,901,486
-2,002,692
| -41% | -$140M |
|
155
TSMC
TSM
$2.18T
| $214M | 0.14% |
2,296,015
+105,009
| +5% | +$9.43M |
|
156
Canadian Natural Resources
CNQ
$96.7B
| $212M | 0.14% |
7,679,004
+562,658
| +8% | +$15.9M |
|
157
Rockwell Automation
ROK
$48.7B
| $211M | 0.14% |
719,355
+1,314
| +0.2% | +$374K |
|
158
Elevance Health
ELV
$86.7B
| $208M | 0.14% |
452,180
+4,436
| +1% | +$2.11M |
|
159
Coca-Cola
KO
$373B
| $204M | 0.13% |
3,292,671
-307,632
| -9% | -$18.6M |
|
|
PXD
160
DELISTED
Pioneer Natural Resource Co.
PXD
| $203M | 0.13% |
992,554
+306,009
| +45% | +$65.8M |
|
161
Vanguard S&P 500 ETF
VOO
$1.03T
| $202M | 0.13% |
537,812
+160,348
| +42% | +$58.8M |
|
162
Occidental Petroleum
OXY
$58.3B
| $202M | 0.13% |
3,238,511
+835,772
| +35% | +$51.9M |
|
163
Neurocrine Biosciences
NBIX
$16.6B
| $202M | 0.13% |
1,994,521
-421,117
| -17% | -$43.8M |
|
164
Sensient Technologies
SXT
$5.52B
| $199M | 0.13% |
2,604,266
+4,243
| +0.2% | +$316K |
|
165
Sempra
SRE
$55.4B
| $199M | 0.13% |
2,627,374
+468,122
| +22% | +$35.9M |
|
166
Alliant Energy
LNT
$17.8B
| $196M | 0.13% |
3,670,327
+25,371
| +0.7% | +$1.35M |
|
167
Palo Alto Networks
PANW
$307B
| $196M | 0.13% |
1,960,208
+1,061,208
| +118% | +$89.9M |
|
168
Blackbaud
BLKB
$2.07B
| $192M | 0.13% |
2,765,818
-41,706
| -1% | -$2.5M |
|
|
HZNP
169
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $190M | 0.13% |
1,738,146
-2,211,373
| -56% | -$244M |
|
170
Tyler Technologies
TYL
$12.9B
| $189M | 0.12% |
531,659
-82,937
| -13% | -$27M |
|
171
AstraZeneca
AZN
$249B
| $186M | 0.12% |
1,337,708
-188,138
| -12% | -$25.3M |
|
172
Autodesk
ADSK
$53B
| $183M | 0.12% |
877,818
-143,825
| -14% | -$29.6M |
|
173
Core & Main
CNM
$8.64B
| $181M | 0.12% |
7,844,638
+31,789
| +0.4% | +$700K |
|
174
STAG Industrial
STAG
$7.11B
| $179M | 0.12% |
5,298,930
+173,697
| +3% | +$5.93M |
|
175
OSI Systems
OSIS
$3.89B
| $179M | 0.12% |
1,749,330
-83,002
| -5% | -$7.69M |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.